Funding for this research was provided by:
Eli Lilly and Company
Received: 24 June 2020
Accepted: 18 March 2021
First Online: 31 March 2021
: Each patient gives his written consent before inclusion in the study.Agence Nationale de Sécurité du Médicament et des Produits de Santé (ANSM): Date of authorization: 18/06/2018Ethic committee: PROTECTION COMMITTEE Ile de France – Paris - Date of approval: 19/06/2018 Ref. CPP: CPPIDF1–2018-ND40-cat. 1ClinicalTrials.gov identifier (NCT number): NCT03958136, registration 21st of May, 2019; retrospectively registered: ExternalRef removed
: Not Applicable.
: The authors declare to have no competing interest.